Professor
David Huang
FAA FAHMS
Professor David Huang is a biomedical researcher who made fundamental research discoveries on programmed cell suicide (apoptosis) that laid the foundations for the discovery and development of a novel class of anti-cancer drugs. Professor Huang made critical contributions towards revealing how BCL2, often overactive in blood cancers, and related proteins block cell death thereby uncovering how BCL2 could be targeted in cancer cells. In collaboration with industry partners, this work led to the development of venetoclax to target BCL2. Venetoclax has proven highly effective and is now approved in Australia and other jurisdictions for patients with certain types of leukaemias and lymphomas.
Fields of research
31 BIOLOGICAL SCIENCES-
3101
BIOCHEMISTRY AND CELL BIOLOGY
- 310102 Cell Development, Proliferation and Death
For full list of research codes, please visit the ARC Website .
Expertise type
- Drug Discovery
- Molecular Biology
- Biology
- Haematology
- Cell Death
- Apoptosis
- Biochemistry
- Cancer Biology
Please contact fellowship@science.org.au to request any updates to the data.